share_log

Form 144 | Soleno Therapeutics(SLNO.US)董事拟出售1.27万股股份,价值约50.66万美元

Form 144 | Soleno Therapeutics(SLNO.US) Director Proposes to Sell 506.64K in Common Stocks

Futu News ·  Jun 29 05:18

SEC FILLINGS DISCLOSED/ Jun 28, $Soleno Therapeutics (SLNO.US)$ Director Melincoff Gwen A intends to sell 12,666 shares of its common stock on Jun 28, with a total market value of approximately $506.64K.

1719609509959498622.png

What is Form 144?

Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment